Question 1

What is the catalog number for HEATR7B2 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

The catalog number for HEATR7B2 CRISPR Knock Out 293T Cell Line (Human) is 23166141.

Question 2

What sizes are available for HEATR7B2 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

HEATR7B2 CRISPR Knock Out 293T Cell Line (Human) is available in the following size(s): 1x 10^6 Cells / 1.0 mL.

Question 3

Is HEATR7B2 CRISPR Knock Out 293T Cell Line (Human) in stock?

Accepted Answer

HEATR7B2 CRISPR Knock Out 293T Cell Line (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 5

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

HEATR7B2 CRISPR Knock Out 293T Cell Line (Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Pmel17 / gp100 / SILV (NKI-beteb), CF594 conjugate, 0.1mg/mL

Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL

CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL

CD53 (161-2), CF647 conjugate, 0.1mg/mL

CD104 (UM-A9), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL